A 2-day-old newborn diagnosed with erythroblastosis fetalis has a bilirubin level of 18 mg/dL and is receiving continuous phototherapy. The parents are concerned about the treatment. Which nursing intervention should be the priority to ensure optimal treatment effectiveness?
A 2-day-old newborn with erythroblastosis fetalis has been placed under phototherapy lights. The infant's bilirubin level is 18 mg/dL, and the physician has ordered continuous phototherapy. The parents are concerned about the treatment and ask about their baby's care.
1Keep the infant clothed to prevent hypothermia during treatment
2Position the infant on one side throughout the entire treatment period
3Cover the infant's eyes only during feeding times to promote bonding
4Maximize skin exposure by removing all clothing except the diaper✓ 정답
해설
Maximizing skin exposure by removing all clothing except the diaper is essential for phototherapy effectiveness, as it allows more bilirubin to be broken down by light. Other options like keeping the infant clothed or covering eyes only during feeding are incorrect and can reduce treatment efficacy.
Core Nursing ExplanationKey Concept Analysis: This question assesses the priority nursing intervention for a newborn receiving Phototherapy for Hyperbilirubinemia (high bilirubin level). The underlying condition is Erythroblastosis fetalis, a hemolytic disease caused by maternal-fetal blood group incompatibility (often Rh or ABO), leading to rapid red blood cell breakdown and a dangerous rise in Bilirubin. Phototherapy works by using specific wavelengths of light to convert unconjugated (indirect) bilirubin in the skin into a water-soluble form that can be excreted without needing liver conjugation. The core principle for effectiveness is maximizing the skin surface area exposed to the therapeutic light.
Answer Rationale: Key Point! The correct answer is to Maximize skin exposure by removing all clothing except the diaper. A bilirubin level of 18 mg/dL in a 2-day-old is significantly elevated (normal term newborn levels are typically < 12 mg/dL by day 3-5, with intervention often starting lower). Continuous, effective phototherapy is critical to prevent Kernicterus (bilirubin-induced brain damage). Clothing blocks the light, drastically reducing treatment efficacy. The diaper is left on to protect the genitalia and contain stool, but the rest of the skin must be exposed.
Distractor Analysis:
Watch out for confusion! Option ①, keeping the infant clothed to prevent hypothermia, addresses a potential side effect but directly contradicts the primary treatment goal. While thermoregulation is important (phototherapy units often have warming features), the nurse must balance this by using servo-controlled warmers or monitoring temperature closely, not by sacrificing skin exposure.
Option ②, positioning on one side, is incorrect. The infant should be repositioned frequently (e.g., every 2-3 hours) to expose all skin surfaces (front, back, sides) evenly to the light and to prevent pressure ulcers and head molding.
Option ③, covering the eyes only during feeding, is a critical safety error. The infant's eyes must be securely covered with opaque eye patches at all times during phototherapy to protect the delicate retina from potential damage by the high-intensity light. Feeding times are no exception.
Related Concepts: Nursing care for phototherapy also includes monitoring vital signs (especially temperature), maintaining hydration (increased insensible water loss), monitoring stool output (bilirubin is excreted in stool), providing parental support and education, and ensuring lab draws for serial bilirubin levels to evaluate treatment effectiveness.
Nursing Clinical Practice GuideClinical Scenario: You are caring for Baby Girl Rodriguez, a 38-week gestation newborn now 48 hours old. She is under blue phototherapy lights for hyperbilirubinemia secondary to ABO incompatibility. Her mother is tearful at the bedside, asking, "Why does my baby have to be naked and wear those patches? Can I hold her?"
Nursing Intervention Strategy:
1AssessmentConfirm eye patches are on securely, assessing for skin irritation. Assess skin color (jaundice), hydration status (skin turgor, fontanels, urine output), and temperature. Review the most recent bilirubin level.
2Nursing DiagnosisRisk for Injury related to phototherapy exposure and sensory deprivation; Risk for Fluid Volume Deficit; Parental Anxiety.
3Planning & Implementation* Treatment Efficacy: Ensure the infant is wearing only a diaper. Measure the distance from the light source to the infant per unit guidelines (usually 12-18 inches). Reposition the infant every 2-3 hours.
* Safety: Eye patches must be on whenever the lights are on. Remove them during feeding only if the infant is completely removed from under the lights (e.g., taken to mother's room for feeding). Check eyes for drainage or irritation with each patch change.
* Hydration & Nutrition: Offer feeds more frequently (every 2-3 hours). Monitor intake and output closely. Weigh diapers. IV fluids may be ordered if oral intake is insufficient.
* Parental Support: Explain the purpose of phototherapy simply: "The special blue light helps break down the yellow pigment (bilirubin) in her skin so her body can get rid of it safely." Encourage bonding by having parents participate in feeding, diaper changes, and holding the baby with the phototherapy lights temporarily turned off for short, scheduled periods.
Patient Safety and Precautions: Never leave eye patches off while under lights. Monitor for bronze baby syndrome (a rare, harmless skin discoloration) and loose, greenish stools (expected). Watch for signs of dehydration (sunken fontanels, decreased urine output).
Nursing Procedure & Medication Flow
* Phototherapy Setup: Verify physician's order. Explain procedure to parents. Place infant in bassinet, remove all clothing, apply diaper. Apply eye patches securely. Turn on phototherapy unit and set distance. Place infant under center of lights.
* Ongoing Care: Check temperature per protocol (e.g., every 4 hours). Change eye patches and assess skin with each feeding. Document position changes, intake/output, and behavioral responses.
* Discontinuation: Phototherapy is typically stopped when the bilirubin level falls safely below the treatment threshold. A rebound check is often ordered 12-24 hours after stopping.
A Word from Your Senior Nurse
"Seeing a tiny newborn under bright lights with patches can be frightening for parents. Your role is to be the calm, knowledgeable guide. You're not just managing a machine; you're caring for a fragile new life and a worried family. Explain that the nakedness is necessary for the 'medicine' (light) to work, and reassure them that holding their baby is not only allowed but encouraged during breaks. Your careful monitoring of bilirubin levels and skin exposure is what prevents neurological injury. This is a perfect example of where nursing science and compassionate care intersect."
Erythroblastosis Fetalis — A hemolytic disease of the newborn caused by maternal antibodies (usually anti-Rh or anti-ABO) crossing the placenta and attacking fetal red blood cells, leading to anemia, hyperbilirubinemia, and hydrops fetalis in severe cases.
Phototherapy — A treatment for hyperbilirubinemia using specific wavelengths of light (blue spectrum) to convert unconjugated bilirubin in the skin into water-soluble isomers that can be excreted in bile and urine without liver conjugation.
Hyperbilirubinemia — An elevated level of bilirubin in the blood. In newborns, it refers to a total serum bilirubin level exceeding the age-specific percentile on the nomogram, requiring monitoring or treatment to prevent kernicterus.
Kernicterus — A rare but serious neurological complication of severe, untreated hyperbilirubinemia where bilirubin crosses the blood-brain barrier and causes permanent brain damage, characterized by athetoid cerebral palsy, hearing loss, and intellectual disabilities.
Unconjugated (Indirect) Bilirubin — The lipid-soluble, water-insoluble form of bilirubin produced from the breakdown of heme in red blood cells. It must be conjugated in the liver to become water-soluble. It is the form that phototherapy acts upon and that is neurotoxic.